American Renal Associates Holdings

American Renal Associates Holdings, Inc., through its subsidiaries, owns and operates kidney dialysis facilities. It also offers outpatient and inpatient dialysis treatments for patients suffering from chronic kidney failure. The company was formerly known as C.P. Atlas Holdings, Inc. and changed its name to American Renal Associates Holdings, Inc. in February, 2011. American Renal Associates Holdings, Inc. was incorporated in 1999 and is based in Beverly, Massachusetts.

Type
Public
HQ
Beverly, US
Founded
1999
Size (employees)
4,030 (est)
American Renal Associates Holdings was founded in 1999 and is headquartered in Beverly, US

Key People at American Renal Associates Holdings

Joseph A. Carlucci

Joseph A. Carlucci

Chief Executive Officer
Syed T. Kamal

Syed T. Kamal

President and Director
Jonathan Wilcox

Jonathan Wilcox

Chief Financial Officer and Principal Accounting Officer
John J. McDonough

John J. McDonough

Chief Operating Officer and Director

American Renal Associates Holdings Office Locations

American Renal Associates Holdings has offices in Beverly and Tampa
Beverly, US (HQ)
500 Cummings Center
Tampa, US
112 18302 Highwoods Preserve Pkwy

American Renal Associates Holdings Data and Metrics

American Renal Associates Holdings Financial Metrics

USD

Net income (FY, 2016)

88.2 m

EBIT (FY, 2016)

126.8 m

Market capitalization (21-Jul-2017)

548 m

Cash (31-Dec-2016)

100.9 m

EV

495.3 m
American Renal Associates Holdings's current market capitalization is $548 m.
USDFY, 2016

General and administrative expense

127.6 m

Operating expense total

623 m

EBIT

126.8 m

Interest expense

(35.9 m)

Pre tax profit

87.5 m

Income tax expense

(753 k)

Net Income

88.2 m
USDFY, 2016

Cash

100.9 m

Accounts Receivable

28.8 m

Inventories

4.7 m

Current Assets

210.4 m

PP&E

170.1 m

Goodwill

573.1 m

Total Assets

986 m

Accounts Payable

31.1 m

Total Debt

48.3 m

Current Liabilities

153.8 m

Total Liabilities

710 m

Additional Paid-in Capital

95.1 m

Retained Earnings

(128.6 m)

Total Equity

145.7 m

Debt to Equity Ratio

0.3 x

Debt to Assets Ratio

0 x

Financial Leverage

6.8 x
USDFY, 2016

Net Income

88.2 m

Depreciation and Amortization

33.9 m

Accounts Receivable

(4.2 m)

Inventories

(385 k)

Accounts Payable

8.6 m

Cash From Operating Activities

172.2 m

Purchases of PP&E

(61.4 m)

Long-term Borrowings

(275.2 m)

Dividends Paid

(30.2 m)

Interest Paid

32.5 m

Income Taxes Paid

16.1 m
Y, 2016

EV/EBIT

3.9 x

EV/CFO

2.9 x

Debt/Equity

0.3 x

Financial Leverage

6.8 x

American Renal Associates Holdings Market Value History

American Renal Associates Holdings Company Life and Culture

You may also be interested in